Siglec-7/CD328 Antibody (194212) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1138H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
HRP
Antibody Source
Monoclonal Mouse IgG2B Clone # 194212
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Siglec‑7/CD328
Gln19-Gly357 (predicted)
Accession # Q9Y286
Gln19-Gly357 (predicted)
Accession # Q9Y286
Specificity
Detects human Siglec‑7/CD328 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human Siglec-2, -3, -5, or -9 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Siglec-7/CD328 Antibody (194212) [HRP]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Siglec-7/CD328
Long Name
Sialic Acid Binding Ig-like Lectin 7
Alternate Names
AIRM1, CD328, QA79, Siglec7
Gene Symbol
SIGLEC7
Additional Siglec-7/CD328 Products
Product Documents for Siglec-7/CD328 Antibody (194212) [HRP]
Product Specific Notices for Siglec-7/CD328 Antibody (194212) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...